The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
80950933 8095093 3 F 201003 20121018 20110818 20121029 EXP US-BIOGENIDEC-2011BI030858 BIOGEN 64.00 YR F Y 0.00000 20121029 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
80950933 8095093 1 PS TYSABRI 1 INTRAVENOUS D 125104 300 MG Intravenous infusion /month
80950933 8095093 2 SS TYSABRI 1 INTRAVENOUS D 125104 300 MG Intravenous infusion /month
80950933 8095093 3 SS TYSABRI 1 INTRAVENOUS D 125104 300 MG Intravenous infusion /month
80950933 8095093 4 SS TYSABRI 1 INTRAVENOUS D 125104 300 MG Intravenous infusion /month
80950933 8095093 5 SS TYSABRI 1 INTRAVENOUS D 125104 300 MG Intravenous infusion /month
80950933 8095093 6 C AMANTIDINE 1 ORAL D 0 100 MG BID
80950933 8095093 7 C BACLOFEN 1 ORAL D 0 20 MG TID
80950933 8095093 8 C VITAMIN D 1 ORAL D 0 400 IU BID
80950933 8095093 9 C SIMVASTATIN 1 ORAL D 0 20 MG BID
80950933 8095093 10 C SENNA 1 D 0 BID
80950933 8095093 11 C CLEARLAX 1 D 0
80950933 8095093 12 C OXYBUTYNIN 1 ORAL D 0 5 MG
80950933 8095093 13 C NYSTATIN POWDER 2 D 0
80950933 8095093 14 C NORTRIPTYLINE 1 ORAL D 0 10 MG BID
80950933 8095093 15 C NITROGLYCERINE 1 D 0
80950933 8095093 16 C METOPROLOL 1 ORAL D 0 25 MG QD
80950933 8095093 17 C METHOCARBAMOL 1 ORAL D 0 750 MG BID
80950933 8095093 18 C METFORMIN 1 ORAL D 0 500 MG BID
80950933 8095093 19 C LOSARTAN 1 ORAL D 0 25 MG QD
80950933 8095093 20 C LEVOTHYROXINE 1 ORAL D 0 0 MG QD
80950933 8095093 21 C FERROUS SULFATE 1 ORAL D 0 325 MG BID
80950933 8095093 22 C DOCUSATE SODIUM 1 D 0
80950933 8095093 23 C DIPHENHYDRAMINE 1 ORAL D 0 25 MG
80950933 8095093 24 C CITALOPRAM 1 ORAL D 0 20 MG QD
80950933 8095093 25 C ACETAMINOPHEN 1 D 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
80950933 8095093 1 Multiple sclerosis
80950933 8095093 2 Multiple sclerosis
80950933 8095093 3 Multiple sclerosis
80950933 8095093 4 Multiple sclerosis
80950933 8095093 5 Multiple sclerosis
80950933 8095093 6 Fatigue
80950933 8095093 7 Muscle spasticity
80950933 8095093 10 Constipation
80950933 8095093 11 Constipation
80950933 8095093 12 Urinary incontinence
80950933 8095093 16 Hypertension
80950933 8095093 17 Muscle spasms
80950933 8095093 18 Diabetes mellitus
80950933 8095093 20 Hypothyroidism
80950933 8095093 21 Anaemia
80950933 8095093 22 Constipation
80950933 8095093 23 Pruritus

Outcome of event

Event ID CASEID OUTC COD
80950933 8095093 OT
80950933 8095093 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
80950933 8095093 Acute myocardial infarction
80950933 8095093 Convulsion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
80950933 8095093 1 20080111 20080307 0
80950933 8095093 2 20090515 20090612 0
80950933 8095093 3 20100106 20110928 0
80950933 8095093 4 20120114 20120229 0
80950933 8095093 5 20120625 20120723 0